Performance status
Performance status is a measure used by physicians and researchers to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient, and to determine appropriate treatment and prognosis.
Overview[edit]
Performance status is often used in oncology (the study of cancer) and is an attempt to quantify cancer patients' general well-being and activities of daily life. This measure can be used to determine whether patients can receive chemotherapy, whether dose adjustment is necessary, and to assess whether inclusion in a clinical trial is appropriate.
Scales[edit]
There are several scales used to measure performance status, including the Eastern Cooperative Oncology Group (ECOG) scale and the Karnofsky Performance Status scale.
Eastern Cooperative Oncology Group (ECOG) scale[edit]
The ECOG scale, also known as the Zubrod score, ranges from 0 to 5, with 0 denoting perfect health and 5 death. It is a simple scale that allows for easy comparison between patients.
Karnofsky Performance Status scale[edit]
The Karnofsky Performance Status scale ranges from 100 to 0, where 100 is "Normal, no complaints, no evidence of disease" and 0 is "Dead". The scale has been used to compare the effectiveness of different therapies and to assess the prognosis of individual patients.
Use in clinical trials[edit]
Performance status is often used in clinical trials to ensure that the results are applicable to the general population of patients with the disease. It is also used to determine eligibility for trials, as patients with a low performance status may not be able to complete the trial or may experience more severe side effects.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
